VC
Vivo Capital Portfolio holdings
AUM
$977M
This Quarter Return
+20.43%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$869M
AUM Growth
+$869M
(-4.1%)
Cap. Flow
-$44.8M
Cap. Flow
% of AUM
-5.16%
Top 10 Holdings %
Top 10 Hldgs %
62.94%
Holding
54
New
3
Increased
9
Reduced
7
Closed
6
Top Buys
| 1 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
$20.2M |
| 2 |
Astria Therapeutics
ATXS
|
$10.1M |
| 3 |
Geron
GERN
|
$9.79M |
| 4 |
Vaxcyte
PCVX
|
$8.39M |
| 5 |
Compass Therapeutics
CMPX
|
$7.83M |
Top Sells
| 1 |
Harmony Biosciences
HRMY
|
$43.8M |
| 2 |
Relmada Therapeutics
RLMD
|
$26.4M |
| 3 |
Ascendis Pharma
ASND
|
$15.1M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$8.67M |
| 5 |
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
|
$7.39M |
Sector Composition
| 1 | Healthcare | 98.63% |
| 2 | Materials | 1.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Relmada Therapeutics
RLMD
$37.2M
| – | – | -713,238 | Closed | -$26.4M |
|
|
ISEE
52
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – | -483,413 | Closed | -$8.67M |
|
|
STSA
53
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| – | – | -1,232,394 | Closed | -$7.39M |
|
|
MTCR
54
DELISTED
Metacrine, Inc. Common Stock
MTCR
| – | – | -146,426 | Closed | -$71K |
|